Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study
Kentaro Ito, Takeharu Yamanaka, Hidetoshi Hayashi, Yoshihiro Hattori, Kazumi Nishino, Haruki Kobayashi, Yuko Oya, Toshihide Yokoyama, Takashi Seto, Koichi Azuma, Tomoya Fukui, Toshiyuki Kozuki, Atsushi Nakamura, Kentaro Tanaka, Katsuya Hirano, Takashi Yokoi, Haruko Daga, Shinya Sakata, Daichi Fujimoto, Masahide Mori, Ken Maeno, Takuya Aoki, Atsuhisa Tamura, Satoru Miura, Satoshi Watanabe, Hiroaki Akamatsu, Osamu Hataji, Kensuke Suzuki, Shigeto Hontsu, Koji Azuma, Akihiro Bessho, Akihito Kubo, M. Okuno, Kazuhiko Nakagawa, Nobuyuki Yamamoto
Topics & Concepts
CrizotinibAlectinibMedicineAnaplastic lymphoma kinaseLung cancerOncologyInternal medicineRetrospective cohort studyCancer researchMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Research StudiesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis